Industry Sponsored Breakfast Symposium

Friday, November 3, 2017
07:99 a.m. - 08:99 a.m.

INTRAROSA™ (prasterone) 6.5 mg vaginal inserts A Novel Treatment for Moderate to Severe Dyspareunia, a Symptom of Vulvar and Vaginal Atrophy (VVA), Due to Menopause¹

1. INTRAROSA™ (prasterone) Prescribing Information. AMAG Pharmaceuticals, Inc.

Marla Shapiro C.M.
MDCM, CCFP, MHSc, FRCPC, FCFP, NCMP
Professor, Family and Community Medicine, University of Toronto
Immediate Past President, North American Menopause Society